Evaxion Biotech A/S
NASDAQ:EVAX
Income Statement
Earnings Waterfall
Evaxion Biotech A/S
Revenue
|
73k
USD
|
Operating Expenses
|
-22.3m
USD
|
Operating Income
|
-22.2m
USD
|
Other Expenses
|
72k
USD
|
Net Income
|
-22.1m
USD
|
Income Statement
Evaxion Biotech A/S
Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Dec-2022 | Jun-2023 | Sep-2023 | Dec-2023 | ||
---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | |||||||||||
Revenue |
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
0
N/A
|
|
Operating Income | |||||||||||
Operating Expenses |
(10)
|
(17)
|
(23)
|
(26)
|
(27)
|
(26)
|
(25)
|
(12)
|
(18)
|
(22)
|
|
Selling, General & Administrative |
(3)
|
(5)
|
(6)
|
(6)
|
(7)
|
(7)
|
(8)
|
(5)
|
(8)
|
(10)
|
|
Research & Development |
(7)
|
(12)
|
(16)
|
(20)
|
(20)
|
(19)
|
(17)
|
(7)
|
(10)
|
(12)
|
|
Depreciation & Amortization |
0
|
0
|
0
|
(0)
|
0
|
0
|
(1)
|
0
|
0
|
(1)
|
|
Other Operating Expenses |
0
|
0
|
0
|
0
|
0
|
0
|
1
|
0
|
0
|
0
|
|
Operating Income |
(10)
N/A
|
(17)
-72%
|
(23)
-35%
|
(26)
-13%
|
(27)
-5%
|
(26)
+3%
|
(25)
+4%
|
(12)
+52%
|
(18)
-47%
|
(22)
-24%
|
|
Pre-Tax Income | |||||||||||
Interest Income Expense |
1
|
0
|
0
|
1
|
1
|
3
|
1
|
(1)
|
(1)
|
(1)
|
|
Pre-Tax Income |
(9)
N/A
|
(17)
-81%
|
(22)
-34%
|
(25)
-10%
|
(26)
-6%
|
(24)
+10%
|
(24)
-1%
|
(13)
+46%
|
(19)
-45%
|
(23)
-22%
|
|
Net Income | |||||||||||
Tax Provision |
1
|
2
|
2
|
0
|
0
|
(0)
|
1
|
0
|
1
|
1
|
|
Income from Continuing Operations |
(8)
|
(15)
|
(20)
|
(25)
|
(26)
|
(24)
|
(23)
|
(13)
|
(18)
|
(22)
|
|
Net Income (Common) |
(8)
N/A
|
(15)
-82%
|
(20)
-35%
|
(25)
-20%
|
(26)
-7%
|
(24)
+8%
|
(23)
+4%
|
(13)
+46%
|
(18)
-45%
|
(22)
-21%
|
|
EPS (Diluted) |
-0.46
N/A
|
-0.82
-78%
|
-1.05
-28%
|
-1.26
-20%
|
-1.13
+10%
|
-1.01
+11%
|
-0.98
+3%
|
-0.46
+53%
|
-6.59
-1 333%
|
-8.09
-23%
|